VCYT — VERACYTE, INC.
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1384101 ·
Last close
$43.60
Market Cap
$3.51B
52W High
$60.91
52W Low
$29.45
ADV30
1,422,812
Next earnings
2026-11-03
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 139,071,000 | 101,159,000 | 22,646,000 | 28,707,000 | 1,436,400,000 | 263,136,000 | 91,994,000 |
| Dec 2025 | 140,636,000 | 101,973,000 | 39,908,000 | 41,149,000 | 1,406,019,000 | 362,578,000 | 96,443,000 |
| Sep 2025 | 131,872,000 | 91,282,000 | 23,112,000 | 19,137,000 | 1,367,787,000 | 315,573,000 | 110,120,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$166,160,000
Investing CF
$-85,352,000
Financing CF
$-4,367,000
CapEx
$-10,820,000
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$1.41
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$-348,923,000
Inventory
$21,416,000
Receivables
$50,112,000
ST Investments
$175,924,000
EBIT TTM
$90,747,000
Pretax Income TTM
$90,747,000
Interest Exp TTM
$0
Analysts
10
Yahoo Snapshot (yfinance, live)
Total Revenue
$561,900,032
EBITDA
$113,515,000
Free Cash Flow
$106,230,872
Enterprise Value
$2,840,444,160
Total Cash
$485,232,000
Total Debt
$40,107,000
Shares Out
80,390,731
Trailing EPS
$1.40
Book Value
$17.28
ROE
8.8%
ROA
4.1%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 517,145,000 | 78,282,000 | 66,353,000 | 1,406,019,000 | 96,443,000 | 1,309,576,000 | 136,307,000 |
| Dec 2024 | 445,764,000 | 19,510,000 | 24,138,000 | 1,300,035,000 | 124,069,000 | 1,175,966,000 | 75,096,000 |
| Dec 2023 | 361,051,000 | -17,446,000 | -74,404,000 | 1,114,906,000 | 70,804,000 | 1,044,102,000 | 44,222,000 |
| Dec 2022 | 296,536,000 | -35,340,000 | -36,560,000 | 1,156,422,000 | 81,222,000 | 1,075,200,000 | 7,535,000 |
TTM Snapshot
Revenues TTM
$541,743,000
NetIncome TTM
$88,013,000
OpCashFlow TTM
—
Assets (Latest)
$1,436,400,000
Forward EPS
$1.95
Max Pain — expiry 2026-11-20 (volume-derived — Yahoo OI feed degraded)
max pain strike: $45.00 · spot: $43.60 · call volume: 18 · put volume: 209
Expected Move to 2026-11-20:
±$13.35
(30.62%) —
implied range
$30.25 –
$56.95
· ATM straddle on $45.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| NHC | NATIONAL HEALTHCARE CORP | $3.53B | $225.17 | — |
| CELC | Celcuity Inc. | $3.32B | $67.87 | — |
| CDNA | CareDx, Inc. | $3.22B | $62.21 | — |
| BLLN | BillionToOne, Inc. | $4.07B | $95.41 | — |
| AVAH | Aveanna Healthcare Holdings, Inc. | $2.67B | $12.24 | — |
News headlines (Yahoo Finance, 1h cache)
Veracyte (VCYT) Stock Still Looks Cheap As Its 107% Run Continues
2026-10-09 05:13 · Yahoo
Veracyte (VCYT) Is Down 9.0% After New Level 1B1 Decipher Prostate Data at ASTRO 2026
2026-10-02 11:09 · Yahoo
Is it the Right Time to Add Phibro Stock to Your Portfolio?
2026-10-08 16:22 · Yahoo
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets
2026-10-08 16:18 · Yahoo
Bruker Gains 66.3% in a Year: What's Driving the Rally?
2026-10-08 13:39 · Yahoo
Reasons to Hold HealthEquity Stock in Your Portfolio for Now
2026-10-07 13:11 · Yahoo
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies
2026-10-07 12:52 · Yahoo
Reasons to Add Globus Medical Stock to Your Portfolio Now
2026-10-07 12:51 · Yahoo
Charles River Gains 75.8% in a Year: What's Driving the Rally?
2026-10-07 12:51 · Yahoo
Is This the Right Time to Add TMO Stock to Your Portfolio?
2026-10-07 12:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.